Tickr
Home Explore Daily Brief Market Watchlists Portfolio
Research
Catalysts Signal Factory Screener Market News Event Calendar Valuation Plot Heat Map Top Investors Industry Trends Options
AI Assistant Notifications Account
GRAIL Inc. logo

GRAIL Inc. (GRAL) Stock Ticker

NASDAQ: GRAL · Healthcare · Medical - Diagnostics & Research
$132.63+1.34%
USD · as of 2026-09-29 · market cap $5.4B
Open GRAL in TickrDownload for iPhone

GRAL right now

Up 66% in a month — 61 points ahead of its industry.
bullishBreaking out: New 52-week high with a golden cross
Tickr signals on GRAL
Breaking outNew 52-week high with a golden cross
Options expect by Oct 6±10.6%
Options expect by Oct 29±21.9%
Priced in for Nov 11 earnings±26.2%
IV rank (30-day)5% · cheap
From Tickr's live models · 2026-09-29. Not investment advice.

Market factors today

Tickr 500 vs S&P 500+0.49%+1.0% MTD
Momentum L/S+1.35%+15.1% MTD
High-beta momo L/S+1.46%+22.2% MTD
Rate sensitivity L/S+1.91%+6.9% MTD
Oil sensitivity L/S-2.54%-5.3% MTD
Unprofitable tech-1.43%+3.7% MTD

Unlock the full GRAL picture

🔒 Implied move chart & probabilities
🔒 Live options flow
🔒 AI analysis & chat on GRAL
🔒 Catalysts & earnings
🔒 Strategy Lab
🔒 Financials & estimates
Start your 7-day free trial

About GRAIL Inc.

GRAIL, Inc., a commercial-stage healthcare company, provides multi-cancer early detection testing and services in the United States and internationally. It offers Galleri, a cancer screening test for asymptomatic individuals over 50 years of age; and a diagnostic aid for cancer tests to accelerate diagnostic resolution for patients with clinical suspicion of cancer. The company also provides development services, including support for ongoing clinical studies, pilot testing, research, and therapy development. In addition, its precision oncology portfolio consists of n RUO-targeted methylation-based platform that enables applications for disease prognostication, risk stratification, minimal residual disease detection, and recurrence and relapse monitoring. The company was incorporated in 2015 and is headquartered in Menlo Park, California.

GRAL stock facts

Ticker symbolGRAL
ExchangeNASDAQ
SectorHealthcare
IndustryMedical - Diagnostics & Research
Market cap$5.4B
CEOJoshua J. Ofman
Employees910
HeadquartersMenlo Park, CA, US
IPO date2024-06-12
Websitewww.grail.com

What you can see for GRAL on Tickr

Live GRAL price chart with overlays, the options chain, implied move, IV rank, options flow and Strategy Lab, financial statements and consensus estimates, analyst ratings, catalysts, news with AI scoring, and an AI chat that has read the GRAL report.

Rankings

Largest Healthcare companiesLargest companies by market cap

FAQ

What is the ticker symbol for GRAIL Inc.?

The ticker symbol for GRAIL Inc. is GRAL, listed on the NASDAQ.

What is GRAL?

GRAIL, Inc., a commercial-stage healthcare company, provides multi-cancer early detection testing and services in the United States and internationally. It offers Galleri, a cancer screening test for asymptomatic individuals over 50 years of age; and a diagnostic aid for cancer tests to accelerate diagnostic resolution for patients with clinical suspicion of cancer. The company also provides…

HomeExploreMarketLists
All pages